VarmX
VarmX is a Netherlands-based biotechnology company manufacturing therapeutic proteins to restore blood clotting in bleeding patients.
7
Funding Rounds
$93.8m
Money raised
Overview
VarmX is a Netherlands-based biotechnology company manufacturing therapeutic proteins to restore blood clotting in bleeding patients.
- Website:
- Business model: B2B
- Headquarters: The Hague
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Bi**** |
|
- | - |
| Pi**** Re***** |
|
- | - |
| Name | Phone | Social networks | |
|---|---|---|---|
| Pa** Bi**** |
|
- | - |
Funding
Funding series
Funding Series Analysis
The company VarmX has raised a total of $45.7m in funding over 7 rounds.
Key Insights:
- VarmX May 2023 Series B Funding Round: $37m
- VarmX Series A round, July 2018: $8.7m
- VarmX Series A Funding Round July 2018: $8.85m
- VarmX Seed Funding Round December 2016: $333k
- VarmX Seed Funding Round June 2017: $1.13m
- VarmX Series B Funding Round July 2020: $37.76m
VarmX May 2023 Series B Funding Round
$37m
VarmX Series A round, July 2018
$8.7m
VarmX Seed Funding Round December 2016
$333k
VarmX Seed Funding Round June 2017
$1.13m
VarmX Series A Funding Round July 2018
$8.85m
VarmX Series B Funding Round July 2020
$37.76m
Industries
VarmX is active in the following industries: